Global Biochip Market

Table of Content

1. Executive Summary

2. Market Analysis
2.1. Market size and growth rates
2.2. Macroeconomic change
2.3. Market growth drivers, market dynamics and trends
2.4. Megatrends and their impact
2.5. Value chain analysis
2.6. Market scenarios and opportunity forecasts
2.7. Relevant markets
2.8. The new frontiers of growth
2.9. Creating value through sustainable strategies

3. Sentiment Analysis
3.1. Internal Friction Analysis: Where workflows are failing
3.2. Budgetary Pivot: Spending intent for next 12 months
3.3. Unmet ROI: Where current solutions are failing
3.4. Risk Aversion: Board-level fears regarding adoption
3.5. Legacy Debt: Technology replacement timelines
3.6. Social Proof: Competitive admiration benchmarking
3.7. Future-Skilling: Labor market shifts and obsolescence
3.8. Decision Maker Psychology: Selection vs. Rejection criteria
3.9. Price Elasticity: The “Too Cheap to Trust” floor
3.10.The Unasked Question: Emerging industry blind spots

4. Market Breakdown by Type
4.1. Introduction
4.2. DNA Chips
4.2.1. Cancer Diagnosis And Treatment
4.2.2. Gene Expression
4.2.3. SNP Genotyping
4.2.4. Genomics
4.2.5. Drug Discovery
4.2.6. Agricultural Biotechnology
4.2.7. Others
4.3. Protein Chips
4.3.1. Proteomics
4.3.2. Expression Profiling
4.3.3. Diagnostics
4.3.4. HTS
4.3.5. Drug Discovery
4.3.6. Others
4.4. Lab-on-chip
4.4.1. Genomics
4.4.2. IVD & POC
4.4.3. Proteomics
4.4.4. Drug discovery
4.4.5. Others
4.5. Tissue Arrays
4.6. Cell Arrays

5. Market Breakdown by End Use
5.1. Introduction
5.2. Biotechnology and Pharmaceutical Companies
5.3. Academic & Research Institutes
5.4. Hospitals and Diagnostic Centers
5.5. Others

6. Market Breakdown by Geography
6.1. North America
6.1.1. U.S.
6.1.2. Canada
6.1.3. Mexico
6.2. South America
6.2.1. Brazil
6.2.2. Argentina
6.2.3. Others
6.3. Europe
6.3.1. Germany
6.3.2. France
6.3.3. U.K.
6.3.4. Italy
6.3.5. Spain
6.3.6. Sweden
6.3.7. Switzerland
6.3.8. Netherlands
6.3.9. Others
6.4. Asia-Pacific
6.4.1. China
6.4.2. Japan
6.4.3. South Korea
6.4.4. India
6.4.5. Australia
6.4.6. Others
6.5. Middle East & Africa
6.5.1. South Africa
6.5.2. Saudi Arabia
6.5.3. UAE
6.5.4. Israel
6.5.5. Others

7. Competitive Landscape
7.1. Competitive situation and trends
7.2. Industry benchmarking
7.3. Maintaining current market share
7.4. Expansion path
7.5. Recent market and industry developments
7.5.1. New product developments and announcements
7.5.2. Agreements, partnerships, joint ventures, and collaborations
7.5.3. Mergers and acquisitions and major PE deals

8. Companies Profiled
8.1. Abbott Laboratories
8.2. Agilent Technologies
8.3. Bio-Rad Laboratories
8.4. Danaher Corporation
8.5. Illumina, Inc.
8.6. Merck KGaA
8.7. PerkinElmer
8.8. QIAGEN
8.9. Roche
8.10.Standard BioTools
8.11.Thermo Fisher Scientific

Request Sample

Buy Now